Matthew Doxey, DPM
Foot & Ankle Surgery · Arkansas City, KSNPI 1619598448
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Titan Surgical Group, LLC at 44.7% of the total. Reporting peaked in 2023 at $816 and has fallen 62.5% since, to $306 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in KS, where the typical reported total is $2,742.
Across 23 payments — averaging $51.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Titan Surgical Group, LLC$531
- Arthrex$278
- Smith+Nephew$116
- Medline Industries LP$46
- Organogenesis Inc.$39
- Biocomposites Inc$37
- plus $141 from 6 others
What the payments were for
- Travel & lodging$70459%
- Food & beverage$48341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Titan Surgical Group, LLC | 4 | $531 |
| Arthrex | 4 | $278 |
| Smith+Nephew | 5 | $116 |
| Medline Industries LP | 1 | $46 |
| Organogenesis Inc. | 2 | $39 |
| Biocomposites Inc | 1 | $37 |
| Treace Medical Concepts, Inc. | 1 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Bioventus LLC | 1 | $26 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Linvatec Corporation | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
How this compares
$1,187 in reported general payments places this provider in the 25th percentile of 40 foot & ankle surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 18 | $168 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Arkansas City
- Greg HortonKansas City$1.1M
- Melissa JournotLeawood$26K
- Zhipeng YangKansas City$25K
- Patrick McGregorLawrence$24K
- Andrea DrielingHutchinson$16K
- John GalliganLawrence$12K
- Lucas CosensSalina$10K
- Sarah RussellLeawood$9K
- Scott GordonPratt$8K
- Steven OstiguyLawrence$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.